The CD8+T cell is a generally recognized anti-tumor defender of the host and serves as one of the most crucial effector cells in anti-cancer immunity, dysfunction of which would result in a severe barrier for cancer elimination (He et al., 2019). Here, CD8A is linked to neoplasm.